Evidence map›Paper›PMID 40143027›Full record

ArticlePharmaceutics2025

Optimized and Functionalized Carvacrol-Loaded Nanostructured Lipid Carriers for Enhanced Cytotoxicity in Breast Cancer Cells.

Ana F C Uchôa, Allessya L D Formiga, Anny L M R Cardoso, Graziela M A Pereira, Lucas M M Carvalho, Pedro H O Souza, Anauara L Silva, Ramon R M Souza, Marianna V Sobral, Marcelo S Silva and 2 more

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Development of OptimizedACS omega · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ana F C UchôaLaboratory of Pharmaceutical Biotechnology (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.ORCID 0000-0001-6872-082X
Allessya L D FormigaLaboratory of Pharmaceutical Biotechnology (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.ORCID 0000-0001-6632-9851
Anny L M R CardosoLaboratory of Pharmaceutical Biotechnology (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.ORCID 0009-0004-9704-7303
Graziela M A PereiraLaboratory of Pharmaceutical Biotechnology (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.
Lucas M M CarvalhoLaboratory of Pharmaceutical Biotechnology (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.ORCID 0009-0002-5570-6046
Pedro H O SouzaLaboratory of Pharmaceutical Biotechnology (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.ORCID 0009-0003-6798-6839
Anauara L SilvaMultiuser Characterization and Analysis Laboratory (LMCA), Institute of Research in Drugs and Medicines, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.ORCID 0009-0003-1765-3008
Ramon R M SouzaOncopharmacology Laboratory (ONCOFAR), Institute of Research in Drugs and Medicines (IPeFarM), Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.ORCID 0009-0002-0651-163X
Marianna V SobralOncopharmacology Laboratory (ONCOFAR), Institute of Research in Drugs and Medicines (IPeFarM), Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.ORCID 0000-0002-7740-034X
Marcelo S SilvaMultiuser Characterization and Analysis Laboratory (LMCA), Institute of Research in Drugs and Medicines, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.ORCID 0000-0003-3451-8468
José M Barbosa-FilhoMultiuser Characterization and Analysis Laboratory (LMCA), Institute of Research in Drugs and Medicines, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.ORCID 0000-0002-9567-4096
Francisco H Xavier-JúniorLaboratory of Pharmaceutical Biotechnology (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, Brazil.ORCID 0000-0001-8238-3380

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancercarvacroldrug deliverynanostructured lipid carriersnanotechnology

Identifiers

PMID40143027
PMCPMC11945829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.